The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease.


Dursun E. , Gezen-Ak D. , Hanagasi H., Bilgic B., Lohmann E., Ertan S., ...Daha Fazla

Journal of neuroimmunology, cilt.283, ss.50-7, 2015 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 283
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.jneuroim.2015.04.014
  • Dergi Adı: Journal of neuroimmunology
  • Sayfa Sayıları: ss.50-7

Özet

Alzheimer's disease (EOAD, LOAD), mild cognitive impairment (MCI), Parkinson's disease (PD) and healthy controls were included to determine the serum interleukin-Is (IL-1 alpha, IL-1 beta), IL-6 and alpha-2-macroglobulin (alpha M-2) levels using ELISA.